These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35521959)

  • 1. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
    Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
    Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.
    Yang B; Zhou ZH; Chen L; Cui X; Hou JY; Fan KJ; Han SH; Li P; Yi SQ; Liu Y
    Cancer Med; 2018 May; 7(5):1756-1765. PubMed ID: 29577671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
    Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
    EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
    World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma.
    Chu LY; Peng YH; Yang T; Fang WK; Hong CQ; Huang LS; Xu LY; Li EM; Xu YW; Xie JJ
    J Cancer; 2020; 11(18):5395-5402. PubMed ID: 32742486
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma.
    Ding TY; Peng YH; Hong CQ; Huang BL; Liu CT; Luo Y; Chu LY; Zhang B; Li XH; Qu QQ; Xu YW; Wu FC
    Discov Oncol; 2022 Nov; 13(1):128. PubMed ID: 36409444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
    Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
    Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Huang Z; Zhou B; Li Z; Liu C; Zheng C; Zeng R; Hong C; Xu L; Li E; Peng Y; Xu Y
    Cancer Biomark; 2020; 29(1):139-149. PubMed ID: 32623391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
    Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
    J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of the presence of
    Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
    Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of auto-quantified tumor-infiltrating lymphocytes and the prognostic value in adenocarcinoma of the esophagogastric junction, gastric adenocarcinoma, and esophageal squamous cell carcinoma.
    Dong H; Yao L; Fan J; Gao P; Yang X; Yuan Z; Zhang T; Lu M; Chen X; Suo C
    Aging (Albany NY); 2024 Jul; 16(13):11027-11061. PubMed ID: 38975889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
    Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
    Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.